Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all synonyms
Protein-protein interactions involving apoptosis regulator Diva (Boo) and the BH3 domain of proapoptotic Bcl-2 (show BCL2 ELISA Kits) members.
analysis of a novel interaction between Bcl-2 (show BCL2 ELISA Kits) members Diva and Harakiri (show HRK ELISA Kits)
Structure and sequence alignment of mouse pro-survival Bcl-2 (show BCL2 ELISA Kits) family members reveals Boo/Diva as a divergent Bcl-2 (show BCL2 ELISA Kits) protein.
The role of Bcl2l10 is strongly associated with oocyte maturation, especially at the MI-MII transition.
BCL2L10 is a novel and prime candidate related to oocyte maturation, fertility, and embryo developmental competence
Identification of a variant in the BCL2L10 gene as a protective factor for the development of therapy-related myeloid neoplasms and de novo myelodysplastic syndrome.
polyubiquitination and proteasomal turnover dictate the expression level and anti-apoptotic capacity of Bcl-B
Data suggest that BCL2L10 is localized predominantly to mitochondria in high-quality preimplantation embryos/blastocysts; in contrast, abnormal embryos/blastocysts exhibit extra-mitochondrial localization (cytoplasm/cell nucleus) of BCL2L10.
Bcl-B in complex with the BH3 motif of Bim (show BCL2L11 ELISA Kits) protected cells from Bax (show BAX ELISA Kits)-dependent apoptotic pathways.
Bcl-B interacts with the BH3 domain of BECN1 (show BECN1 ELISA Kits) and Bcl-B overexpression reduces autophagy triggered by a variety of pro-autophagic stimuli.
Ubqln stabilizes BCLb protein, while also promoting monoubiquitination on multiple lysine residues and relocation to the cytosol.
BCL2L10 methylation is associated with myelodysplastic syndromes.
Loss of BCL2L10 protein expression predicts poor clinical outcome in gastric carcinoma.
The apoptotic gene BCL2L10 is a frequent target for aberrant promoter methylation in patients with acute leukemia, de novo and therapy-related.
The pro-apoptotic effect of BCL2L10 and growth promotion by BCL2L10 siRNA in gastric cancer cells suggest that it may be a tumour suppressor.
The protein encoded by this gene belongs to the BCL-2 protein family. BCL-2 family members form hetero- or homodimers and act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities. The protein encoded by this gene contains conserved BH4, BH1 and BH2 domains. This protein can interact with other members of BCL-2 protein family including BCL2, BCL2L1/BCL-X(L), and BAX. Overexpression of this gene has been shown to suppress cell apoptosis possibly through the prevention of cytochrome C release from the mitochondria, and thus activating caspase-3 activation. The mouse counterpart of this protein is found to interact with Apaf1 and forms a protein complex with Caspase 9, which suggests the involvement of this protein in APAF1 and CASPASE 9 related apoptotic pathway.
anti-apoptotic protein Boo
, apoptosis regulator Bcl-B
, bcl-2 homolog Diva
, bcl-2-like protein 10
, anti-apoptotic protein NrH